A Medical Device Daily
James Hickey Jr., who has headed several other medical device companies, has been named president and CEO of Myocor (Maple Grove, Minnesota), a manufacturer of implantable devices to repair heart valves and treat congestive heart failure.
The appointment comes, the company said, as it focuses on completing enrollment in the RESTOR-MV clinical trial of its Coapsys Mitral Repair System and prepares for clinical trials of its percutaneous, catheter-based mitral valve repair technology.
From 2001-2005, Hickey guided privately held ventilation manufacturer Pulmonetic Systems, before the company was acquired by Viasys in June of last year. He served as president and CEO of Angeion, a maker of implantable cardioverter defibrillators, from 1998-2000 and prior to that held the same posts with Aequitron Medical, a manufacturer of respiratory care devices, from 1993-1997.
Hickey also spent 15 years with Baxter International's American Hospital Supply unit, serving in a variety of executive roles, including president of its Respiratory/Anesthesia and Hospitex divisions.
Myocor Chairman Gordie Nye said: “Jim Hickey has a great track record of growing companies effectively and profitably. He understands how to drive a culture of quality and performance. He is the right leader to build on the solid foundation Myocor has already established.“
Hickey said, “We have a significant opportunity to help cardiovascular surgeons and cardiologists treat their patients less invasively with better long-term outcomes. Our current focus is developing a broad network of physicians and medical centers to complete the pivotal trials we believe will demonstrate the safety and efficacy of our devices in treating functional mitral regurgitation.“